Product Information
OSELTAMIVIR PHOS 30 MG CAPSULE is a generic product labeled by Camber Pharmaceuticals Inc., priced at $0.6950 per EA under NDC 31722063031. Its NADAC has been published 428 times since Jun 13, 2018.
FDA first approved this application on Feb 23, 2018. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
30 mg/1
Manufacturer
Camber Pharmaceuticals Inc.NDC
31722063031
Classification
Generic
Dosage Form
CAPSULE
Route
ORAL
Effective Date
8/19/2026
Active Ingredients
OSELTAMIVIR PHOSPHATEApproval Type
Generic (ANDA)
FDA Application
ANDA209438FDA Approved
2/23/2018
TE Code
AB
On Market Since
2/23/2018
Price Statistics
The NADAC for OSELTAMIVIR PHOS 30 MG CAPSULE has been published 428 times since Jun 13, 2018, and over the history we have for it it has declined 90.6%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.6950 per EA |
|---|---|
| All-time high | $8.1216 (Oct 10, 2018) |
| All-time low | $0.6013 (Aug 20, 2025) |
| 52-week high | $0.8323 |
| 52-week low | $0.6013 |
| Median price | $1.5864 |
| Average price | $2.5667 |
| Largest weekly change | +62.9% (Jan 25, 2023) |
| Weeks tracked | 428 |
| Tracking since | Jun 13, 2018 |
Generic Alternatives
The matcher finds 1 manufacturer offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of OSELTAMIVIR PHOS 30 MG CAPSULE?
The current National Average Drug Acquisition Cost (NADAC) for OSELTAMIVIR PHOS 30 MG CAPSULE, manufactured by Camber Pharmaceuticals Inc., is $0.6950 per EA (NDC 31722063031), effective Aug 19, 2026.
How has the price of OSELTAMIVIR PHOS 30 MG CAPSULE changed over time?
Over the history we have for it, the NADAC for OSELTAMIVIR PHOS 30 MG CAPSULE has declined 90.6%. It has been tracked across 428 weekly CMS publications since Jun 13, 2018.
What are the highest and lowest recorded NADAC prices for OSELTAMIVIR PHOS 30 MG CAPSULE?
Since Jun 13, 2018, the NADAC for OSELTAMIVIR PHOS 30 MG CAPSULE has ranged from a low of $0.6013 (Aug 20, 2025) to a high of $8.1216 (Oct 10, 2018), with a median of $1.5864 per EA.
Are there cheaper alternatives to OSELTAMIVIR PHOS 30 MG CAPSULE?
1 manufacturer publishes a NADAC-priced product with the same active ingredient and strength as OSELTAMIVIR PHOS 30 MG CAPSULE in a comparable dosage form, but none are currently priced below it.
Who manufactures OSELTAMIVIR PHOS 30 MG CAPSULE?
OSELTAMIVIR PHOS 30 MG CAPSULE (NDC 31722063031) is labeled by Camber Pharmaceuticals Inc., and CMS classifies it as a generic product.